APEIRON Biologics Competitors and Similar CompaniesClear all
APEIRON Biologics's competitors and similar companies include OxThera, KBP Biosciences, Abivax and Tetherex.
 APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  OxThera OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate. |  KBP Biosciences KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases. |  Abivax Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. | |
Founding Date | Founding Date 2005 | Founding Date N/A | Founding Date 2007 | Founding Date 2013 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Wien, AT HQ | Locations Stockholm, SE HQ Knoxville, US | Locations Princeton, US HQ Jinan Shi, CN | Locations Paris, FR HQ Montpellier, FR Montpellier, FR Waltham, US | Locations Oklahoma City, US HQ Morrisville, US |
Employees | Employees 5 | Employees 7 | Employees 46 | Employees 69 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr11m (FY, 2015) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income (kr37.8m) (FY, 2015) | Net income N/A | Net income (€336.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 76m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 43m (about 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 53.3m | Total funding raised $ 76m | Total funding raised $ 13.5m | Total funding raised $ 46.2m |
For sources of this data, please see the company profile
View Company Profiles
OxThera
HQ
Stockholm, SE
Employees
7
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
View companyKBP Biosciences
HQ
Princeton, US
Employees
46
KBP is developing a pipeline of new chemical entities with known mechanisms of action in areas of unmet medical need in cardiovascular, infectious disease, respiratory, inflammatory and autoimmune diseases.
View companyAbivax
HQ
Paris, FR
Employees
69
Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer.
View companyTetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View company